Avecho Biotechnology Limited

A$0.01As of Sun 8 Nov 2026, 12:00 UTC
ASX:AVEHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (9.92%)
Div yield —
ROE (268.21%)
Biotechnology
Beta (5Y) 1.27
PE TTM —
TSR TTM 100.00%
Mkt cap A$46.36M
ROIC (133.51%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0138
14.98%
207.71%
Sell 0|1|10|8|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
31.01%
27.31%
25.06%
13.90%
Revenue$M
5.999
6.119
6.042
5.900
7.99%
4.43%
0.99%
1.10%
Peers (US$31.84M)
Cap (US$)
PE
31.89M
—
Capital
TTM
5Y
10Y
Leveragex
0.612
1.005
0.616
EBIT/Intx
6.771
0.139
0.138
Own earn%
159.08
134.41
129.06
Sh yield%
21.57
34.45
35.13
Owners
Insiders/Inst%
8.26
62.92
Short interest%
0.70
SBC / revenue%
5.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
14–20
$1 testx
—
Incr. ROIC%
2